Nuvelo, Inc.

Novelo, Inc.

Douglas Dedera

Radoje Drmanac

Y Tom Tang

Chenghua Liu

Vinod Asundi

Jian-Rui Wang

Peter C R Emtage

Jian Rui Wang

Victoria Yamazaki

Peter Emtage

Certain cells, including types of cancer cells such as lymphomas, are capable of expressing high levels of CD84Hy1. Immunotargeting using CD84Hy1 polypeptides, nucleic acids encoding for CD84Hy1 polypeptides and anti-CD84Hy1 antibodies provides a method of killing or inhibiting that growth of CD84HY1Protein-expressing cancer cells. Methods of immunotherapy and diagnosis of disorders associated with CD84Hy1 protein-expressing cells are described.

Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells

The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to novel human secreted IGFBP-like polypeptides. Other aspects of the invention include vectors containing processes for producing novel human secreted IGFBP-like polypeptides, compositions, and methods of use for such polypeptides including in cancer.

Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides

Certain cells, including types of cancer cells such as lymphomas, are capable of expressing high levels of CD84Hy1. Immunotargeting using CD84Hy1 polypeptides, nucleic acids encoding for CD84Hy1 polypeptides and anti-CD84Hy1 antibodies provides a method of killing or inhibiting that growth of CD84HY1Protein-expressing cancer cells. Methods of immunotherapy and diagnosis of disorders associated with CD84Hy1protein-expressing cells are described.

Growing community of inventors

Castro Valley, CA, United States of America

Douglas Dedera